The licensing pact adds a second so-called "triple agonist" to the Danish drugmaker's portfolio as competition with Lilly and ...

Population-based analyses of new vaccination programmes provide robust real-world evidence for post-licensure vaccine evaluation. A 2023–24 vaccine effectiveness analysis of immunocompetent adults ...

This is the latest sign of global healthcare giants doubling down on the market in recent years. Experts noted on Monday that ...

Recent spinoffs with good payouts include Kenvue, Carrier Global, Organon, Kontoor Brands, Phinia, and Sylvamo.

China will continue to welcome enterprises from around the world with open arms, further expand market access, actively ...

China will continue to welcome enterprises from around the world with open arms, further expand market access, actively address the concerns of businesses, and facilitate the deeper integration of ...

Novo Nordisk stock dropped Monday after the drugmaker licensed a Chinese competitor's weight-loss drug for $200 million up ...

Get the latest news today on Sun Pharmaceutical Industries Ltd. Follow Business Standard for the complete news coverage and key information about the Sun Pharmaceutical Industries Ltd.

The global virology market is on track for significant expansion, with projections indicating a steady rise from USD 2,333.2 ...

UPS today announced fourth-quarter 2024 consolidated revenues of $25.3 billion, a 1.5% increase from the fourth quarter of 2023.